The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection

Antibody-dependent enhancement (ADE) has been proposed as a mechanism to explain dengue hemorrhagic fever (DHF) in the course of a secondary dengue infection. Very recently, Dejnirattisai et al., 2010 [1], published an important article supporting the involvement of anti-prM antibodies in the ADE phenomenon. The complexity of ADE in the context of a secondary dengue infection is discussed here.

[1]  A. Nisalak,et al.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.

[2]  J. Roehrig,et al.  Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells , 2001, Journal of Virology.

[3]  J. Roehrig,et al.  The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein , 1992, Virology.

[4]  M. Guzmán,et al.  Race: a risk factor for dengue hemorrhagic fever , 2006, Archives of Virology.

[5]  A. Nisalak,et al.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.

[6]  S. Halstead.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. , 1970, The Yale journal of biology and medicine.

[7]  D. Hober,et al.  Antibody-Dependent Enhancement of Coxsackievirus B4 Infectivity of Human Peripheral Blood Mononuclear Cells Results in Increased Interferon-α Synthesis , 2001 .

[8]  M. Nuwer.  Overview and history , 2008 .

[9]  T. Pierson,et al.  Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection , 2008, Expert Reviews in Molecular Medicine.

[10]  P. Puthavathana,et al.  Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection , 2008, Journal of Virology.

[11]  Mojgan Kavoosi,et al.  Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. , 2002, The Journal of general virology.

[12]  G. Nybakken,et al.  Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody , 2009, The EMBO journal.

[13]  A. Ling,et al.  Retrospective study of western blot profiles in immune sera of natural dengue virus infections , 1999, Journal of medical virology.

[14]  S. Kalayanarooj,et al.  Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. , 2007, The Journal of general virology.

[15]  Bimmi Shrestha,et al.  Immunopathology of flavivirus infections , 2007, Immunology and cell biology.

[16]  Richard J Kuhn,et al.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins , 2008, Nature Structural &Molecular Biology.

[17]  S. Halstead,et al.  Immune enhancement of viral infection. , 1982, Progress in allergy.

[18]  M. Guzmán,et al.  Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  Phyllis Kanki,et al.  HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. , 2007, Human immunology.

[20]  M. Guzmán,et al.  Dengue: an update. , 2002, The Lancet. Infectious diseases.

[21]  M. Guzmán,et al.  Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  M. Guzmán,et al.  Human Dengue Antibodies against Structural and Nonstructural Proteins , 2000, Clinical Diagnostic Laboratory Immunology.

[23]  J. Smit,et al.  Immature Dengue Virus: A Veiled Pathogen? , 2010, PLoS pathogens.

[24]  S. Halstead.  Etiologies of the experimental dengues of Siler and Simmons. , 1974, The American journal of tropical medicine and hygiene.

[25]  F. Guirakhoo,et al.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model , 1989, Journal of virology.

[26]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[27]  M. Guzmán,et al.  Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). , 1987, Bulletin of the Pan American Health Organization.

[28]  S. Gollins,et al.  Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate. , 1984, The Journal of general virology.

[29]  A. Nesburn,et al.  Antibody-dependent enhancement of HSV-1 infection by anti-gK sera. , 2000, Virus research.

[30]  Brian R. Murphy,et al.  Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys , 2005, Journal of Virology.

[31]  S. Sirinavin,et al.  Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. , 1991, The American journal of tropical medicine and hygiene.

[32]  C. Mandl,et al.  Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. , 1994, Virology.

[33]  Prida Malasit,et al.  Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans , 2010, Science.

[34]  R. Rico-Hesse.  Dengue virus evolution and virulence models. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  S. Halstead,et al.  Effect of age on outcome of secondary dengue 2 infections. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[36]  S. Halstead,et al.  Neutralizing Antibodies after Infection with Dengue 1 Virus , 2007, Emerging infectious diseases.

[37]  Y. Modis,et al.  A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Guzmán,et al.  Neutralizing antibody response variation against dengue 3 strains , 2008, Journal of medical virology.

[39]  M. Bray,et al.  Dengue virus premembrane and membrane proteins elicit a protective immune response. , 1991, Virology.

[40]  V. Stollar,et al.  Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. , 1990, Virology.

[41]  C. Mandl,et al.  Resuscitating Mutations in a Furin Cleavage-Deficient Mutant of the Flavivirus Tick-Borne Encephalitis Virus , 2005, Journal of Virology.

[42]  D. Gubler.  Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.

[43]  G. Bruening.  RESISTANCE to infection. , 1955, British medical journal.

[44]  P. Malasit,et al.  Alterations of pr-M Cleavage and Virus Export in pr-M Junction Chimeric Dengue Viruses , 2004, Journal of Virology.

[45]  F. Guirakhoo,et al.  Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. , 1991, The Journal of general virology.

[46]  M. Accavitti-Loper,et al.  Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. , 2009, Virology.

[47]  E. Konishi,et al.  Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels , 2007, Journal of Virology.

[48]  M. Guzmán,et al.  Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. , 1998, Emerging infectious diseases.

[49]  S. Harrison,et al.  The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.

[50]  Susana Vázquez,et al.  Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. , 2006, The American journal of tropical medicine and hygiene.

[51]  C. Hackett,et al.  Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. , 1991, The American journal of tropical medicine and hygiene.

[52]  D. Burke,et al.  Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. , 1989, The American journal of tropical medicine and hygiene.

[53]  M. Guzmán,et al.  Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. , 1988, Bulletin of the Pan American Health Organization.

[54]  M. Guzmán,et al.  Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. , 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[55]  G. Chinea,et al.  Immune response to synthetic peptides of dengue prM protein. , 2002, Vaccine.

[56]  C. King,et al.  High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. , 2003, Virology.

[57]  A. Barrett,et al.  The Infectious Agent , 2008 .

[58]  M. Guzmán,et al.  Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[59]  Yee‐Shin Lin,et al.  The Dual-Specific Binding of Dengue Virus and Target Cells for the Antibody-Dependent Enhancement of Dengue Virus Infection1 , 2006, The Journal of Immunology.

[60]  M. St. Claire,et al.  Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention , 2007, Proceedings of the National Academy of Sciences.

[61]  M. Lai.  Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription. , 1998, Virology.

[62]  J. Stephenson.  Understanding dengue pathogenesis: implications for vaccine design. , 2005, Bulletin of the World Health Organization.

[63]  S. Halstead,et al.  Epidemiologic studies on Dengue in Santiago de Cuba, 1997. , 2000, American journal of epidemiology.

[64]  Wei Zhang,et al.  Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation , 2008, Science.

[65]  A. Sabin.  Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.

[66]  D. Fremont,et al.  Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. , 2007, Cell host & microbe.

[67]  M. Guzmán,et al.  Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. , 2010, The American journal of tropical medicine and hygiene.

[68]  S. Halstead.  In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.

[69]  M. Guzmán,et al.  [Epidemiology of dengue and hemorrhagic dengue in Santiago, Cuba 1997]. , 1999, Revista panamericana de salud publica = Pan American journal of public health.

[70]  S. Halstead,et al.  Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. , 2001, The American journal of tropical medicine and hygiene.

[71]  J. Roehrig,et al.  Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. , 1998, Virology.

[72]  A. Nisalak,et al.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.

[73]  M. Guzmán,et al.  Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. , 1989, Bulletin of the World Health Organization.

[74]  M. Loeb,et al.  Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus , 2006, Journal of Virology.

[75]  M. Guzmán,et al.  La epidemiología del dengue y del dengue hemorrágico en Santiago de Cuba, 1997 , 1999 .

[76]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[77]  Susana Vázquez,et al.  Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.

[78]  L. Rosen,et al.  Dengue hemorrhagic fever. , 1996, Bulletin de la Societe de pathologie exotique.

[79]  M. Diamond,et al.  Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification , 2010, PLoS pathogens.

[80]  Ralph S. Baric,et al.  Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses , 2010, PLoS pathogens.

[81]  James E. Robinson,et al.  Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient , 2010, Virology Journal.

[82]  S. Gollins,et al.  Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry. , 1985, The Journal of general virology.

[83]  J. Smit,et al.  Functional importance of dengue virus maturation: infectious properties of immature virions. , 2008, The Journal of general virology.

[84]  Charles M. Rice,et al.  Flaviviridae :T he Viruses and Their Replication , 2007 .

[85]  D. Burke,et al.  Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. , 1985, The American journal of tropical medicine and hygiene.

[86]  B. Lidbury,et al.  Specific Ablation of Antiviral Gene Expression in Macrophages by Antibody-Dependent Enhancement of Ross River Virus Infection , 2000, Journal of Virology.

[87]  S. Halstead,et al.  Dengue , 1872, The Lancet.

[88]  J. Roehrig,et al.  Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. , 1983, Virology.

[89]  W. Dunsmuir,et al.  Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. , 2007, The Journal of infectious diseases.